1-methyl-4-phenyl-2,3-dihydropyridinium has been researched along with Atherosclerotic Parkinsonism in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (50.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| McCrodden, JM; Sullivan, JP; Tipton, KF | 1 |
| Misra, HP; Zang, LY | 1 |
| Chacón, JN; Chedekel, MR; Land, EJ; Truscott, TG | 1 |
| Castagnoli, N; Ramsay, RR; Singer, TP; Trevor, AJ | 1 |
1 review(s) available for 1-methyl-4-phenyl-2,3-dihydropyridinium and Atherosclerotic Parkinsonism
| Article | Year |
|---|---|
Metabolic aspects of the behavior of MPTP and some analogues.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; Animals; Corpus Striatum; Humans; Monoamine Oxidase; Parkinson Disease, Secondary; Pyridinium Compounds; Structure-Activity Relationship; Substantia Nigra | 1993 |
3 other study(ies) available for 1-methyl-4-phenyl-2,3-dihydropyridinium and Atherosclerotic Parkinsonism
| Article | Year |
|---|---|
EPR kinetic studies of superoxide radicals generated during the autoxidation of 1-methyl-4-phenyl-2,3-dihydropyridinium, a bioactivated intermediate of parkinsonian-inducing neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Cyclic N-Oxides; Electron Spin Resonance Spectroscopy; Free Radicals; Humans; Hydrogen-Ion Concentration; Kinetics; Mathematics; Oxidation-Reduction; Parkinson Disease, Secondary; Pyridinium Compounds; Spin Labels; Superoxides | 1992 |
Chemically induced Parkinson's disease. II: Intermediates in the oxidation and reduction reactions of the 1-methyl-4-phenyl-2,3-dihydropyridinium ion and its deprotonated form.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Electrons; Humans; Indicators and Reagents; Kinetics; Oxidation-Reduction; Parkinson Disease, Secondary; Photolysis; Pyridines; Pyridinium Compounds; Spectrophotometry | 1989 |
Biochemical events in the development of parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; Animals; Biotransformation; Brain; Humans; Mitochondria; Monoamine Oxidase; NAD; Parkinson Disease, Secondary; Pyridines; Pyridinium Compounds; Rats | 1987 |